Alethia® Group B Streptococcus


Meridian Bioscience Alethia® Group B Streptococcus

Molecular assay for the detection of Group B Streptococcus. Alethia provides a quick, accurate and reliable molecular assay for Group B Strep detection.

The Alethia Platform from Meridian Bioscience helps you provide molecular accuracy when testing for GBS in expectant mothers. The molecular precision of Alethia Group B Strep test ensures accurate results and timely administration of appropriate antibiotic therapy for GBSpositive patients.

Most infants who develop GBS disease are born to mothers who tested negative for Group B Strep.

  • Culture sensitivity has been shown to be unreliable and is documented to be as low as 42%.
  • Broth enrichment and AlethiaTM Group B Strep increased detection of positives by up to 29% over culture for the detection of Group B Streptococcus.
  • Pregnant moms and their families are hoping for a joyful birth experience. Give your labs and expectant mothers peace of mind with a definitive answer from the Alethia Group B Strep test.

If your lab currently screens for GBS with culture, the implications could be significant:

  • Can you trust your negative culture and ensure your lab doesn’t miss a non-hemolytic GBS strain?
  • What are the implications of missing a GBS positive?


Click here for product brochure